Nemaura Pharma Limited sell "Memspatch"

This proprietary micro-injector system delivers liquid injectables through the skin to different controlled depths. It has been developed alongside reformulations of sumatriptan for migraine and fentanyl for breakthrough pain, among other small and large molecules currently in development, with regulatory submissions planned within 1-2 years.